- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01024166
Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study
A Usability Study of Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: Integrating PROs and Decision Support Into an Electronic Record
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Patient-Reported Outcomes (PRO) Computer System:
The PRO computer system used in this study has been designed to help doctors and nurses check the symptoms and overall health status of patients with cancer by reviewing the computer entries of patients and caregivers. The system has also been designed to help doctors and nurses make decisions about how to care for patients based on the computer entries.
Questionnaire and Review Session:
If you agree to take part in this study, you will have an questionnaire and review session at the Palliative Care outpatient clinic. The session will be conducted by a research staff member, but the study chair and/or other study staff members may also attend the session. The questionnaire and review session will have 3 steps, which are described below:
- If you are a patient receiving palliative care, you will use the PRO computer system to complete 2 questionnaires about any symptoms you may be experiencing and your overall health. If you are a caregiver for someone who is receiving palliative care, you will use the PRO computer system to complete 2 questionnaires about any symptoms that the patient you are caring for may be experiencing and their overall health. The study staff will instruct you on how to use the PRO computer system.
- If you are a physician or nurse, you will use the PRO computer system to complete 4 questionnaires about the symptoms and overall health of patients who are receiving palliative care. The study staff will instruct you on how to use the PRO computer system.
- You will then look at the results of the questionnaires you have completed, which will be shown to you in both number and graph form. You will also be shown other features and potential uses of the PRO computer system.
- Last, you will be asked about how easily you were able to use the computer system. You will also be asked about any changes you think could make the program easier to use.
The questionnaire and review session should take about 30 minutes to complete.
Study Data:
Your responses to the questionnaires will be destroyed after the questionnaire and review session. The responses you give when asked about the use of the PRO computer system will be kept after the questionnaire and review session. Only the study staff will have access to your responses. However, your responses will be coded with a study ID number, not by your name. Your saved responses will be stored in password-protected files that are available only to the study staff for 3 years.
Length of Study:
Your participation in this study will be over after you complete the questionnaire and review session.
This is an investigational study.
Up to 9 patients and 9 caregivers will take part in this study. All will be enrolled at M. D. Anderson.
Up to 9 physicians and nurses (4-5 of each) will take part in this study. All will be enrolled at M. D. Anderson.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- UT MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patient/caregiver participants will be adults 21 years of age or older.
- Participants will be palliative care cancer patients and/or their designated caregivers.
- Participating patients should be receiving palliative care at the MD Anderson Cancer Center as an inpatient or have attended at least one outpatient appointment; participating caregivers should have provided care to their patient during an inpatient stay or have attended at least one outpatient appointment with their patient.
- Physicians and nurses who are experts in palliative care will be eligible for study participation. For this study's purposes, a physician or nurse with a minimum of four years of experience working in a palliative care setting will be considered an expert in palliative care.
Exclusion Criteria:
- Patients or caregivers who are not able to report on symptom status using the electronic measurement system.
- Patient, caregivers, physicians, or nurses who do not agree to sign the study's informed consent documents.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient
Patient computer system use questionnaire
|
Use PRO computer system to complete 2 questionnaires about any symptoms patient may be experiencing and their overall health, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
Use PRO computer system to complete 4 questionnaires about symptoms their overall health of patients, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
|
|
Caregiver
Caregiver computer system use questionnaire
|
Use PRO computer system to complete 2 questionnaires about any symptoms patient may be experiencing and their overall health, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
Use PRO computer system to complete 4 questionnaires about symptoms their overall health of patients, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
|
|
Healthcare Provider
Physician and Nurse computer system use questionnaire
|
Use PRO computer system to complete 2 questionnaires about any symptoms patient may be experiencing and their overall health, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
Use PRO computer system to complete 4 questionnaires about symptoms their overall health of patients, 30 minutes to complete.
Review session about use of computer system and suggested changes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of System Usability of the Prototype Solution (Questionnaire Responses)
Time Frame: Single assessment point
|
Single assessment point
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Michael A. Kallen, PhD, UT MD Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2009-0776
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancers
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterGateway for Cancer Research; Theravalues, Inc.CompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterGE HealthcareWithdrawn
-
M.D. Anderson Cancer CenterEuropean CommissionCompletedAdvanced CancersUnited States, Spain, France, Israel
-
Aeglea BiotherapeuticsCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterFoundation MedicineCompleted
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterSabinsa CorporationWithdrawnAdvanced Cancers
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
Shanghai Chia Tai Tianqing Pharmaceutical Technology...Recruiting
Clinical Trials on Questionnaire and Review Session
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterRecruitingCutaneous MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Recurrent Cervical Carcinoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Stage I Uterine... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Ramsay Générale de SantéGCS Ramsay Santé pour l'Enseignement et la RechercheCompletedFasciitis, Plantar | Aponeurosis ContusionFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingChronic Disease | Infectious DisorderUnited States